These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15475319)
1. MipTec: breaking down the silos of information. Yates I Drug Discov Today; 2004 Oct; 9(20):871-3. PubMed ID: 15475319 [No Abstract] [Full Text] [Related]
2. Optimizing the impact of genomics on drug discovery and development. Crooke ST Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260 [No Abstract] [Full Text] [Related]
3. In biomarkers we trust? Baker M Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081 [No Abstract] [Full Text] [Related]
4. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening]. Schirlin D; Galvan M; Le Fur G Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426 [TBL] [Abstract][Full Text] [Related]
5. In the pursuit of industrial proteomics. Mitchell P Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565 [No Abstract] [Full Text] [Related]
6. The power of genomics to transform the biotechnology industry. Haseltine WA Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259 [No Abstract] [Full Text] [Related]
7. In silico drug discovery: tools for bridging the NCE gap. Larvol BL; Wilkerson LJ Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262 [No Abstract] [Full Text] [Related]
8. Venturing into drug discovery. Steinmetz M Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255 [No Abstract] [Full Text] [Related]
10. Is there a best strategy for drug discovery? Warne P; Page C Drug News Perspect; 2003 Apr; 16(3):177-82. PubMed ID: 12819816 [TBL] [Abstract][Full Text] [Related]
12. Trends in the development of chiral drugs. Caner H; Groner E; Levy L; Agranat I Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394 [No Abstract] [Full Text] [Related]
14. Development trends for therapeutic antibody fragments. Nelson AL; Reichert JM Nat Biotechnol; 2009 Apr; 27(4):331-7. PubMed ID: 19352366 [No Abstract] [Full Text] [Related]
15. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser. Valenzano KJ Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548 [No Abstract] [Full Text] [Related]
16. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
17. Carlo Incerti. Incerti C Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428 [No Abstract] [Full Text] [Related]
18. The impact of systems approaches on biological problems in drug discovery. Hood L; Perlmutter RM Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453 [No Abstract] [Full Text] [Related]
19. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
20. Back to the future: driving innovation in drug development. Wagner JA Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681 [No Abstract] [Full Text] [Related] [Next] [New Search]